实验室检查：凝血酶原时间(PT)延长。
用于生化研究，防止凝血酶原转变成凝血酶。
Used for biochemical studies, to prevent the prothrombin into thrombin.
目的：探讨凝血酶原时间测定的部分影响因素。
Objective: to investigate the part influence factors of prothrombin time assay.
目的：研究凝血酶原活性与肝硬化病人预后的关系。
Objective: To study the relationship between prothrombin coagulative activity and the prognosis of patients with liver cirrhosis.
目的探讨米非司酮对血小板、血浆凝血酶原时间的影响。
Objective to explore effects of blood platelets and prothrombin time on mifepristone.
结果所有受检者均未发现凝血酶原G20210A基因突变。
Results No prothrombin gene G20210A mutation was found in both patients and controls.
当组织损伤时，释放出凝血致活酶，把凝血酶原变成凝血酶。
When the tissue damage, the release of thromboplastin to prothrombin into thrombin.
此外，血清胆红素水平开始下降，部分凝血酶原时间恢复正常。
In addition, the serum bilirubin level began to decrease and the partial-thromboplastin time returned to normal.
凝血酶原基因g20210a突变，可导致血浆凝血酶原水平升高。
Prothrombin G20210A mutation can lead to plasma prothrombin level increase.
结论凝血酶原突变基因20210A可能增加了胃癌的遗传易感性。
Conclusion Prothrombin 20210a gene mutation may increase genetic susceptibility of gastric cancer.
然而，观察期间在总胆红素和凝血酶原时间方面两组之间没有显著差异。
However, there was no significant difference in the total bilirubin and prothrombin time in either group during the observation periods.
大多数肝硬化腹水的患者凝血酶原时间延长并有一定程度的血小板减少。
The majority of patients with ascites due to cirrhosis have prolongation of the prothrombin time and some degree of thrombocytopenia.
诱癌早期的大鼠血浆即出现了高水平异常凝血酶原，它可用于肝癌的早期诊断。
In contrast, there wag no abnormal prothrombin in the rat plasma during its liver regeneration.
组给予中药煎汤另服华法林钠，使血浆凝血酶原时间保持在正常的1 5倍左右；
Group A was given herbal medicine soup together with Warfarin Sodium Tablets, keeping plasma thrombinogen time at 1.5 times as normal.
治疗组血小板计数、凝血酶原时间及血浆黏度变化与对照组相似（P>0.05）。
There was no significant difference in platelet count, plasma prothrombin time and plasma viscosity between treatment group and control group ( P > 0.05) .
目的应用两步凝胶色谱法制备高纯度、高安全性的人凝血酶原复合物(PCC)制剂。
Purpose to establish the preparation procedure of human prothrombin complex concentrate (PCC) by using two-step gel chromatography to obtain high purity and high security product.
目的：制备结合凝血酶原复合物(PCC)的阴离子脂膜微泡，评价微泡的理化性质。
Purpose: the purpose of this study is to prepare prothrombin complex concentrate (PCC) conjugated anionic lipid microbubbles and to assess the physiochemical properties of the microbubbles.
凝血酶原时间和国际标准化比值应仔细监测患者同时管理ISTODAX和香豆衍生物。
Prothrombin time and International Normalized Ratio should be carefully monitored in patients concurrently administered ISTODAX and Coumadin derivatives.
目的通过对国产人凝血酶原复合物(PCC)质量的研究，建立与国际接规的质量标准。
PurposeTo study on the quality of human prothrombin complex concentrate so as to establish the same quality standard as the international standard of PCC.
比较了血浆置换前后患者临床症状、肝肾功能、电解质、凝血酶原活动度、血常规变化等。
The result of liver function, renal function, electrolyte, prothrombin time activity (PTa), blood routine before and after the treatment were analyzed.
目的探讨根据凝血酶原活动度（PTA）预测重型肝炎高胆红素血症行血浆置换的临床疗效。
Objective To evaluate the treatment of plasma exchange(PE) in patients with chronic severe hepatitis based on prothrombin activity(PTA).
优化了CG - 6型大孔阴离子交换树脂从人血浆中吸附和分离凝血酶原复合物的工艺条件。
Technical conditions for adsorption and separation of prothrombin complex concentrates from human plasma with CG-6 macroporous anion-exchange resin were optimized.
前言： 目的：自制凝血酶原片段F1+2单克隆抗体，探讨其在血栓性疾病中的诊断作用。
Objective:To prepare a monoclonal antibody against prothrombin fragment 1+2(F1+2) and study its diagnostic effect in patients with thromboembolism.
常用化疗药环磷酰胺能损伤机体的凝血系统，导致大鼠凝血酶原时间和部分凝血酶原时间的延长。
The common chemotherapy medicine cytoxan (CTX) can damage the body's coagulation and prolong the PT and KPTT time.
目的评价采用凝血酶原时间(PT)监测心脏机械型瓣膜置换术后患者口服华法林治疗效果的意义。
Objective: to monitor the curative effect of oral warfarin for the patients after heart mechanical valve displacement by the prothrombin time (PT).
用ACL-200型血液凝集仪测定大鼠凝血酶原时间（PT）和部分凝血活酶时间（APTT）。
The prothrombin time(PT) and the active partial thromboplastin time(APTT) were measured by the ACL- 200 antomatic blood agglutination instrument.
结论：联合应用冷沉淀与凝血酶原复合物在创伤性失血患者治疗中，联合输注组比单独输注组疗效更显著。
Conclusion: Combination of cryoprecipitate and prothrombin complex concentrate for traumatic hemorrhage has better effects than cryoprecipitate or prothrombin complex concentrate alone.
目的探讨不同的抗凝血体外贮存条件对凝血酶原时间（PT）、活化部分凝血活酶时间（APTT）的影响。
Objective To investigate the effects of different storage temperatures on anticoagulated blood hemagglutination tests, including prothrombin time(PT), and activated partial thromboplastin time(APTT).
考察了其对血浆中总蛋白和凝血酶原复合物的吸附情况及吸附等温线，以及影响凝血酶原复合物活性的因素。
The adsorption behaviors and adsorption isothermals of total proteins and prothrombin complex concentrates and the effect factors on activity of prothrombin complex concentrates were investigated.
目的探讨临产孕妇血小板、凝血酶原时间、活化部分凝血活酶时间、凝血酶时间、纤维蛋白原检测的临床意义。
Objective To explore the clinical significance of platelet, prothrombin time , activated partial thromboplastin time , thrombin time , plasma fibrinogen for parturient women.
应用推荐